Search

Search Funnelback University

Search powered by Funnelback
10 results 20 results 50 results
Relevance Date (Newest first) Date (Oldest first) Title (A-Z) Title (Z-A) Distance URL (A-Z) URL (Z-A) Shuffle
Your query has been expanded to news |u:www.enterprize.cam.ac.uk.  Search for news |u:www.enterprise.cam.ac.uk instead.
11 - 22 of 22 search results for news |u:www.enterprise.cam.ac.uk or news |u:www.enterprize.cam.ac.uk

  1. Fully-matching results

  2. Bamboo cricket bat

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26236
    1 Jul 2024: DEVELOPED BY RESEARCHERS FROM CAMBRIDGE'S CENTRE FOR NATURAL MATERIAL INNOVATION, THIS NEW. ... Our bamboo cricket bats representa significant leap forward in cricket bat technology, and we look forward topartnering with leading bat manufacturers to
    By: Cambridge Enterprise

  3. High energy density lithium-sulfur batteries

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26280
    1 Jul 2024: It is also anticipated that this technology will open up a host of new weight-criticalapplications for lithium batteries which have previously been limited byperformance.
    By: Cambridge Enterprise

  4. BloodCounts! an early warning system for infections outbreaks

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26294
    1 Jul 2024: TECHNOLOGY OVERVIEW. We have developed an artificial intelligence tool that uses routine full blood countsto detect new disease outbreaks in a population.
    By: Cambridge Enterprise

  5. MutREAD – Mutational Signature Detection by Restriction…

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=23223
    1 Jul 2024: A new chemistry of adapters for rapid library preparation (ready in few hours).
    By: Cambridge Enterprise

  6. Real-time autofocus for videomicroscopy

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26290
    1 Jul 2024: He developed 3 new angiographic techniques, including haemoglobin videoimaging (HVI), which has since been used to evaluate systemic disorders and theeffects of systemic therapies on microcirculations.
    By: Cambridge Enterprise

  7. Ortho-quinone prodrug strategy (self-immolative linkers)

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=23187
    1 Jul 2024: 0194). SELF-IMMOLATIVE LINKERS FOR PROTECTION ANDCONTROLLED RELEASE OF ORTHO-QUINONES. New C–C bond-cleaving elimination that is pH dependent.
    By: Cambridge Enterprise

  8. Polymer Masterbatch: Customized High-Performance Composite for Your…

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=27120
    1 Jul 2024: Polymer Masterbatch: Customized High-Performance Composite for Your Needs. BACKGROUND. Nanoparticle composites are a unique class of materials that combine nano-sizedparticles with a matrix material, creating polymers with new and
    By: Cambridge Enterprise

  9. Cambridge Centre for Resilience and Sustainable Development

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26239
    1 Jul 2024: robust new, workable solutions to some of the world’s most complexchallenges.
    By: Cambridge Enterprise

  10. Scalable Production of High-Quality Printable Graphene

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=27114
    1 Jul 2024: TECHNOLOGY OVERVIEW. The technology is a new, simple, scalable and effective method to exfoliategraphite into graphene in a controllable way.
    By: Cambridge Enterprise

  11. Single vessel green ammonia production

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26240
    1 Jul 2024: Page 2/4. High efficiency is achieved through our new heat integration technology using amulti-chamber system able to recover and deliver heat for the periodic, self-sufficient regeneration of the
    By: Cambridge Enterprise

  12. LGR5 monoclonal antibody for cancer immunotherapy

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=23572
    1 Jul 2024: LGR5 monoclonal antibody for cancerimmunotherapy. BACKGROUND. In 2020, there were 1.9 million new cases of colorectal cancer, which is the 3rdmost common cancer worldwide. ... As a therapeutic target, LGR5 is relatively new but has been validated in a
    By: Cambridge Enterprise

  13. MAT2A inhibitors to treat BK polyomavirus disease

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=28102
    1 Jul 2024: The groundbreaking discovery opens new avenues forantiviral drug development and offers a promising therapeutic option for BKPyV-associated diseases, addressing the limitations of available treatments. ... Taken together, these results highlight the
    By: Cambridge Enterprise

Refine your results

clear all

Format

clear all

Date

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.